![Scott Reents](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Reents
Director of Finance/CFO at
TOBIRA THERAPEUTICS INC
Net worth: 8 M $ as of 2026-05-30
Profile
Mr. Scott T.
Reents is a President & Director at Cerevel Therapeutics Holdings, Inc., a Chief Financial Officer & Executive Vice President at AbbVie, Inc., a Chief Financial Officer at Tobira Therapeutics, Inc., a Manager at Pharmacyclics LLC, a President at Landos Biopharma, Inc., a President & Director at Allergan GI Corp., a President & Director at Allergan, Inc., a President & Director at Celsius Therapeutics, Inc. and a President & Director at Oculeve, Inc. He is on the Board of Directors at Cerevel Therapeutics Holdings, Inc., Allergan GI Corp., Allergan, Inc., Celsius Therapeutics, Inc. and Oculeve, Inc. Mr. Reents was previously employed as a Vice President-Tax by Abbott Laboratories.
He received his undergraduate degree from the University of Nebraska, a graduate degree from the University of Washington and an MBA from the University of Washington.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-05 | 38,777 ( 0% ) | 8 M $ | 2026-05-30 |
Scott Reents active positions
| Companies | Position | Start |
|---|---|---|
| TOBIRA THERAPEUTICS INC | Director of Finance/CFO | - |
| ABBVIE INC. | Director of Finance/CFO | 2022-06-22 |
| ALLERGAN, INC. | President | - |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | President | 2024-07-31 |
| LANDOS BIOPHARMA, INC. | President | - |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | - |
Oculeve, Inc.
 Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment | President | - |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | President | - |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | President | - |
Former positions of Scott Reents
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Training of Scott Reents
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
36
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
University of Nebraska
 University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
- Stock Market
- Insiders
- Scott Reents
